Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 2
1964 2
1981 7
1982 5
1983 6
1984 6
1985 11
1986 7
1987 12
1988 10
1989 21
1990 17
1991 20
1992 17
1993 17
1994 13
1995 27
1996 27
1997 37
1998 47
1999 44
2000 50
2001 77
2002 88
2003 95
2004 129
2005 144
2006 178
2007 211
2008 267
2009 309
2010 350
2011 393
2012 434
2013 584
2014 633
2015 747
2016 819
2017 883
2018 1016
2019 1249
2020 1490
2021 1728
2022 2000
2023 2154
2024 985

Text availability

Article attribute

Article type

Publication date

Search Results

15,513 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for liang x
Search for LiFang X instead (3 results)
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: liang x. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models.
Ren F, Aliper A, Chen J, Zhao H, Rao S, Kuppe C, Ozerov IV, Zhang M, Witte K, Kruse C, Aladinskiy V, Ivanenkov Y, Polykovskiy D, Fu Y, Babin E, Qiao J, Liang X, Mou Z, Wang H, Pun FW, Ayuso PT, Veviorskiy A, Song D, Liu S, Zhang B, Naumov V, Ding X, Kukharenko A, Izumchenko E, Zhavoronkov A. Ren F, et al. Among authors: liang x. Nat Biotechnol. 2024 Mar 8. doi: 10.1038/s41587-024-02143-0. Online ahead of print. Nat Biotechnol. 2024. PMID: 38459338
Progress in small-molecule inhibitors targeting PD-L1.
Xu J, Kong Y, Zhu P, Du M, Liang X, Tong Y, Li X, Dong C. Xu J, et al. Among authors: liang x. RSC Med Chem. 2024 Mar 4;15(4):1161-1175. doi: 10.1039/d3md00655g. eCollection 2024 Apr 24. RSC Med Chem. 2024. PMID: 38665838 Review.
SESAM mode-locked Yb:GdScO3 laser.
Guo J, Li S, Zhao C, Hang Y, Zeng HJ, Lin ZL, Zhang G, Elabedine GZ, Mateos X, Loiko P, Petrov V, Chen W, Liang X. Guo J, et al. Among authors: liang x. Opt Express. 2024 Feb 26;32(5):7865-7872. doi: 10.1364/OE.512293. Opt Express. 2024. PMID: 38439456 Free article.
Catalytic asymmetric carbenoid α-C-H insertion of ether.
Li X, Yue SH, Tan ZY, Liu SB, Luo DX, Zhou YJ, Liang XW. Li X, et al. Among authors: liang xw. RSC Adv. 2024 May 13;14(21):15167-15177. doi: 10.1039/d4ra02206h. eCollection 2024 May 2. RSC Adv. 2024. PMID: 38741618 Free PMC article. Review.
Permeable Bioelectronics toward Biointegrated Systems.
Lee S, Liang X, Kim JS, Yokota T, Fukuda K, Someya T. Lee S, et al. Among authors: liang x. Chem Rev. 2024 May 22;124(10):6543-6591. doi: 10.1021/acs.chemrev.3c00823. Epub 2024 May 10. Chem Rev. 2024. PMID: 38728658 Review.
The potential role of hydrogen sulfide in cancer cell apoptosis.
Gao W, Liu YF, Zhang YX, Wang Y, Jin YQ, Yuan H, Liang XY, Ji XY, Jiang QY, Wu DD. Gao W, et al. Among authors: liang xy. Cell Death Discov. 2024 Mar 6;10(1):114. doi: 10.1038/s41420-024-01868-w. Cell Death Discov. 2024. PMID: 38448410 Free PMC article. Review.
Amplitude Analysis of the B^{0}→K^{*0}μ^{+}μ^{-} Decay.
Aaij R, Abdelmotteleb ASW, Abellan Beteta C, Abudinén F, Ackernley T, Adeva B, Adinolfi M, Adlarson P, Agapopoulou C, Aidala CA, Ajaltouni Z, Akar S, Akiba K, Albicocco P, Albrecht J, Alessio F, Alexander M, Alfonso Albero A, Aliouche Z, Alvarez Cartelle P, Amalric R, Amato S, Amey JL, Amhis Y, An L, Anderlini L, Andersson M, Andreianov A, Andreola P, Andreotti M, Andreou D, Anelli A, Ao D, Archilli F, Argenton M, Arguedas Cuendis S, Artamonov A, Artuso M, Aslanides E, Atzeni M, Audurier B, Bacher D, Bachiller Perea I, Bachmann S, Bachmayer M, Back JJ, Bailly-Reyre A, Baladron Rodriguez P, Balagura V, Baldini W, Baptista de Souza Leite J, Barbetti M, Barbosa IR, Barlow RJ, Barsuk S, Barter W, Bartolini M, Baryshnikov F, Basels JM, Bassi G, Batsukh B, Battig A, Bay A, Beck A, Becker M, Bedeschi F, Bediaga IB, Beiter A, Belin S, Bellee V, Belous K, Belov I, Belyaev I, Benane G, Bencivenni G, Ben-Haim E, Berezhnoy A, Bernet R, Bernet Andres S, Bernstein HC, Bertella C, Bertolin A, Betancourt C, Betti F, Bex J, Bezshyiko I, Bhom J, Bieker MS, Biesuz NV, Billoir P, Biolchini A, Birch M, Bishop FCR, Bitadze A, Bizzeti A, Blago MP, Blake T, Blanc F, Blank JE, Blusk S, Bobulska D, Bocharn… See abstract for full author list ➔ Aaij R, et al. Among authors: liang x. Phys Rev Lett. 2024 Mar 29;132(13):131801. doi: 10.1103/PhysRevLett.132.131801. Phys Rev Lett. 2024. PMID: 38613276
Value China's deserts beyond energy projects.
Yang C, Mao K, Liang X, Xue Y. Yang C, et al. Among authors: liang x. Science. 2024 Mar 22;383(6689):1302. doi: 10.1126/science.ado0596. Epub 2024 Mar 21. Science. 2024. PMID: 38513013 No abstract available.
15,513 results
You have reached the last available page of results. Please see the User Guide for more information.